Lysine-specific demethylase 5A (KDM5A), known as a histone H3K4 demethylase [4], has recently become a promising therapeutic target for cancers due to its key roles in important cancer processes including tumorigenesis, metastasis, and drug tolerance [5]. This evidence concerns the gene KDM5A and cancer.